NCT04715100

Brief Summary

Background. The recurrence of hemarthrosis in patients with congenital coagulopathies favors the development of a progressive, degenerative intra-articular lesion (hemophilic arthropathy) that mainly affects the knees, ankles and elbows. Disability and functional limitations are characteristic sequelae of these patients from an early age. Objective. To assess the joint status, the perception of quality of life, the performance of roles and the performance of daily life activities, in patients with hemophilic arthropathy. Study design. Observational, multicenter study. Method. 70 patients with hemophilia A and B will be included in this study. Patients will be recruited from 4 centers in different regions of Spain. The dependent variables will be: pain (measured with the Visual Analogue Scale), joint status (Hemophilia Joint Health Score), perception of quality of life (SF-36 questionnaire), list of roles, performance of daily life activities (Barthel scale), performing the instrumental activities of daily life (Lawton and Brody scale). The evolution of the variables will be analyzed using parametric (t-student or ANOVA) or non-parametric (Wilcoxon or Friedman) tests. A correlation analysis will be carried out between the dependent and independent variables, as well as a linear regression analysis between the observed determining variables. Expected results. The aim is to observe the relationship of pain and joint status in patients with hemophilic arthropathy, with their perception of quality of life, the development of the roles they play and the performance of basic and instrumental activities of daily living.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 20, 2021

Completed
1.2 years until next milestone

Study Start

First participant enrolled

April 5, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
Last Updated

October 6, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

January 14, 2021

Last Update Submit

October 5, 2022

Conditions

Keywords

Hemophilic arthropathyEducational interventionJoint painQuality of lifeAnxietyStress

Outcome Measures

Primary Outcomes (2)

  • Assess the perception of joint pain with numerical scale of pain

    Measurement with numerical scale of pain. The patient must assign pain to a numerical value between two extreme points (0 to 10). Although the subject is asked to use numerical values to indicate the level of pain, the use of keywords, as well as previous instructions, are necessary if we expect the patient to conceptualize their pain in numerical terms. The scale is discrete, not continuous, but to perform statistical analyzes, equal intervals can be assumed between categories (score 0-10; higher scores mean a worse joint pain).

    Screening visit

  • Assess the joint status with Hemophilia Joint Health Score

    Measurement the joint status with the instrument: Haemophilia Joint Health Score (score 0-120; higher scores mean a worse joint status).

    Screening visit

Secondary Outcomes (4)

  • Assess the perception of quality of life with the questtionaire Short Form 36 Health Survey

    Screening visit

  • Assess the list of roles with Oakley scale

    Screening visit

  • Assess the carrying out activities of daily living

    Screening visit

  • Assess the instrumental activities of daily living

    Screening visit

Study Arms (1)

Experimental group

The inclusion criteria to participate in the present study are patients: with a diagnosis of hemophilia A and B; adults; and on a prophylactic or on-demand treatment regimen with FVIII / FIX concentrates. For their part, patients with: neurological or cognitive alterations that impede understanding of the questionnaires will be excluded from the study; Dependent patients who require help from a third person to get around; patients who have developed a hemarthros in the 4 weeks prior to the study; and those who have not signed the informed consent document. For inclusion in the study, patients will continue to be administered the dose of FVIII / FIX concentrates, following the guidelines of the medical criteria established by their reference hematologist. Throughout this study, the medical criteria for drug treatment, the dosage, and the replacement treatment periods will not be changed.

Other: Observational group

Interventions

The study dependent variables will be: pain (vas scale), joint status (Hemophilia Joint Health Score), perception of quality of life (SF-36 questionnaire), list of roles (Oakley questionnaire), performance of basic activities of daily life (Barthel index) and the performance of instrumental activities of daily living (Lawton and Brody scale).

Experimental group

Eligibility Criteria

Age18 Years - 65 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with hemophilia attending in hemophilia Associations into Spanish Federation of Hemophilia (Fedhemo).

You may qualify if:

  • Patients diagnosed with hemophilia A and B
  • Patients of legal age
  • Patients on prophylactic or on demand treatment with clotting factor concentrates.

You may not qualify if:

  • Patients with neurological or cognitive disorders that impede the understanding of the questionnaires
  • Dependent patients who require help from a third person to get around
  • Patients who have developed a hemarthros in the 4 weeks prior to the study.
  • Patients who have not signed the informed consent document.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Murcia

Murcia, 30006, Spain

Location

Related Publications (1)

  • Seoane-Martin ME, Cuesta-Barriuso R, Rodriguez-Martinez MC. Performance of instrumental activities of daily living in patients with haemophilic arthropathy. A cross-sectional cohort study. Haemophilia. 2024 Nov;30(6):1406-1413. doi: 10.1111/hae.15114. Epub 2024 Oct 24.

MeSH Terms

Conditions

ArthralgiaAnxiety Disorders

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Rubén Cuesta-Barriuso, PhD

    Universidad de Murcia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2021

First Posted

January 20, 2021

Study Start

April 5, 2022

Primary Completion

June 30, 2022

Study Completion

November 1, 2022

Last Updated

October 6, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations